about
Generating evidence on a risk-based monitoring approach in the academic setting - lessons learnedNot fit for purpose: the ethical guidelines of the Indian Council of Medical Research.Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?Prioritising Healthcare Workers for Ebola Treatment: Treating Those at Greatest Risk to Confer Greatest Benefit.Naming it 'nano': Expert views on 'nano' terminology in informed consent forms of first-in-human nanomedicine trials.Researchers' interpretations of research integrity: A qualitative study.Challenges of clinical translation in nanomedicine: A qualitative study.Is failure to raise concerns about misconduct a breach of integrity? Researchers' reflections on reporting misconductAutonomy and dying: Notes about decision-making and "completed life" euthanasia in the NetherlandsHow do researchers acquire and develop notions of research integrity? A qualitative study among biomedical researchers in SwitzerlandAccommodating an Uninvited Guest: Perspectives of Researchers in Switzerland on 'Honorary' Authorship
P50
Q36279006-EDA82774-3F15-434C-A63D-678FE41ED969Q38432567-8A8DE162-53DA-4AF0-8A63-F9CD13938AA5Q38587494-9750072F-9EA5-4C98-81B3-E4F5EE24FB5BQ40170680-60E8313C-10C3-4287-A993-BD53C409E9CCQ42696414-C4F5A996-EBEB-4F23-97E2-295E90E97F01Q47226807-54BA8F8B-9940-435A-917F-833898AF58A8Q48882695-CC25B703-1923-47FA-BE50-AAD502229DBFQ89315681-A1061150-5AD9-4665-A689-1D1CB760400BQ90626239-C4615724-CD84-4884-925D-8D932D63F825Q90751480-B2E9651B-4D85-430F-A48F-8580FC730FD3Q91561976-5A3669AD-62F8-4AFC-ACD5-AED4BB7D0471
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Priya Satalkar
@ast
Priya Satalkar
@en
Priya Satalkar
@es
Priya Satalkar
@nl
Priya Satalkar
@sl
type
label
Priya Satalkar
@ast
Priya Satalkar
@en
Priya Satalkar
@es
Priya Satalkar
@nl
Priya Satalkar
@sl
prefLabel
Priya Satalkar
@ast
Priya Satalkar
@en
Priya Satalkar
@es
Priya Satalkar
@nl
Priya Satalkar
@sl
P108
P106
P21
P31
P496
0000-0003-2769-8931